Waxman D J, Morrissey J J, Naik S, Jauregui H O
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115.
Biochem J. 1990 Oct 1;271(1):113-9. doi: 10.1042/bj2710113.
The induction of hepatic cytochromes P-450 by phenobarbital (PB) was studied in rat hepatocytes cultured for up to 5 weeks on Vitrogen-coated plates in serum-free modified Chee's medium then exposed to PB (0.75 mM) for an additional 4 days. Immunoblotting analysis indicated that P-450 forms PB4 (IIB1) and PB5 (IIB2) were induced dramatically (greater than 50-fold increase), up to levels nearly as high as those achieved in PB-induced rat liver in vivo. The newly synthesized cytochrome P-450 was enzymically active, as shown by the major induction of the P-450 PB4-dependent steroid 16 beta-hydroxylase and pentoxyresorufin O-dealkylase activities in the PB-induced hepatocyte microsomes (up to 90-fold increase). PB induction of these P-450s was markedly enhanced by the presence of dexamethasone (50 nM-1 microM), which alone was not an affective inducing agent, and was inhibited by greater than 90% by 10% fetal bovine serum. The PB response was also inhibited (greater than 85%) by growth hormone (250 ng/ml), indicating that this hormone probably acts directly on the hepatocyte when it antagonizes the induction of P-450 PB4 in intact rats. In untreated hepatocytes, P-450 RLM2 (IIA2), P-450 3 (IIA1) and NADPH P-450 reductase levels were substantially maintained in the cultures for 10-20 days. The latter two enzymes were also inducible by PB to an extent (3-4 fold elevation) that is comparable with that observed in the liver in vivo. Moreover, P-450c (IA1) and P-450 3 (IIA1) were highly inducible by 3-methylcholanthrene (5 microM; 48 h exposure) even after 3 weeks in culture. In contrast, the male-specific pituitary-regulated P-450 form 2c (IIC11) was rapidly lost upon culturing the hepatocytes, suggesting that supplementation of appropriate hormonal factors may be necessary for its expression. The present hepatocyte culture system exhibits a responsiveness to drug inducers that is qualitatively and quantitatively comparable with that observed in vivo, and should prove valuable for more detailed investigations of the molecular and mechanistic basis of the response to PB and its modulation by endogenous hormones.
在无血清改良Chee培养基中,于涂有Vitrogen的培养板上培养大鼠肝细胞长达5周,然后再用苯巴比妥(PB,0.75 mM)处理4天,以此研究PB对肝细胞色素P - 450的诱导作用。免疫印迹分析表明,P - 450形式的PB4(IIB1)和PB5(IIB2)被显著诱导(增加超过50倍),达到的水平几乎与PB诱导的大鼠肝脏在体内所达到的水平一样高。新合成的细胞色素P - 450具有酶活性,如在PB诱导的肝细胞微粒体中P - 450 PB4依赖性类固醇16β - 羟化酶和戊氧基试卤灵O - 脱烷基酶活性的主要诱导(增加高达90倍)所示。地塞米松(50 nM - 1 μM)的存在显著增强了PB对这些P - 450的诱导作用,地塞米松单独作用时不是有效的诱导剂,而10%胎牛血清可抑制PB诱导作用超过90%。生长激素(250 ng/ml)也抑制PB反应(超过85%),这表明该激素在完整大鼠中拮抗P - 450 PB4诱导时可能直接作用于肝细胞。在未处理的肝细胞中,P - 450 RLM2(IIA2)、P - 450 3(IIA1)和NADPH P - 450还原酶水平在培养10 - 20天期间基本保持稳定。后两种酶也可被PB诱导一定程度(升高3 - 4倍),这与在体内肝脏中观察到的情况相当。此外,即使在培养3周后,3 - 甲基胆蒽(5 μM;暴露48小时)也能高度诱导P - 450c(IA1)和P - 450 3(IIA1)。相反,雄性特异性垂体调节的P - 450形式2c(IIC11)在培养肝细胞时迅速消失,这表明补充适当的激素因子对其表达可能是必要的。目前的肝细胞培养系统对药物诱导剂的反应在定性和定量方面与体内观察到的情况相当,并且对于更详细地研究对PB反应的分子和机制基础以及内源性激素对其的调节应具有重要价值。